One of the most common alteration in non‐small‐cell lung cancer (NSCLC) patients and cells is overexpression of EGFR, which is demonstrated in more than half cases of NSCLC and is associated with a poor prognosis and chemoresistance 6, 7. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.